Cylert

Lea en español

CylertCylert is the brand name for Pemoline, a stimulant first synthesized in 1913 and used to treat ADHD (attention deficit hyperactivity disorder) and narcolepsy. Pemoline has been pulled from the U.S. market because of reports connecting its use in children to increased risk of liver failure. After the U.S. Food and Drug Administration (FDA) issued a warning not to prescribe Pemoline for ADHD, the manufacturer and patent owner (Abbott Laboratories) stopped making Cylert.

Pemoline was first approved by the FDA in 1975. Since that date, more than 20 liver failures have been linked to the drug. Pemoline is believed to cause hepatoxicity, a chemically induced form of liver damage.

If you or someone you love has used any type of Cylert and experienced detrimental side effects, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Avoiding Probate

I often am asked by clients how they can avoid probate. In some situations, it is appropriate to tak…

12 Jul 2019, Friday

What is the Hatch Act and How Did Kellyanne Conway Violate It?

Office of Special Counsel Calls White House Counselor a “Repeat Offender” and Calls for…

25 Jun 2019, Tuesday

TEVA Pharmaceutical Settles Opioid Lawsuit Before Trial

Israeli Drug Company Agrees to Pay $85 Million A second major pharmaceutical company has decided to…

28 May 2019, Tuesday